Cargando…
Bupropion Use and Risk of Open-Angle Glaucoma among Enrollees in a Large U.S. Managed Care Network
OBJECTIVE: Tumor Necrosis Factor (TNF) mediates retinal ganglion cell death in glaucoma. Anti-TNF drugs are neuroprotective in an animal model of glaucoma. It is unclear whether medications with anti-TNF properties such as bupropion have an impact on the risk of developing open-angle glaucoma (OAG)...
Autores principales: | Stein, Joshua D., Talwar, Nidhi, Kang, Jae H., Okereke, Olivia I., Wiggs, Janey L., Pasquale, Louis R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4395241/ https://www.ncbi.nlm.nih.gov/pubmed/25875446 http://dx.doi.org/10.1371/journal.pone.0123682 |
Ejemplares similares
-
Reproductive factors and NOS3 variant interactions in primary open-angle glaucoma
por: Kang, Jae Hee, et al.
Publicado: (2011) -
Low-carbohydrate-diet scores and the risk of primary open-angle glaucoma: data from three US cohorts
por: Hanyuda, Akiko, et al.
Publicado: (2020) -
Plasma metabolite profile for primary open-angle glaucoma in three US cohorts and the UK Biobank
por: Zeleznik, Oana A., et al.
Publicado: (2023) -
206 The Role of Mechanosensitive Ion Channels in Primary Open Angle Glaucoma
por: Liu, Wendy, et al.
Publicado: (2022) -
Cohort Study of Race/Ethnicity and Incident Primary Open-Angle Glaucoma Characterized by Autonomously Determined Visual Field Loss Patterns
por: Kang, Jae H., et al.
Publicado: (2022)